Report overview
Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms.
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.
This report aims to provide a comprehensive presentation of the global market for Virtual Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Clinical Trials. This report contains market size and forecasts of Virtual Clinical Trials in global, including the following market information:
Global Virtual Clinical Trials Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Virtual Clinical Trials market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Interventional Trials Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Virtual Clinical Trials include ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable, Oracle and CRF Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Virtual Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Virtual Clinical Trials Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Virtual Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Interventional Trials
Observational Trials
Expanded Access Trials
Global Virtual Clinical Trials Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Virtual Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiovascular Disease
Others
Global Virtual Clinical Trials Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Virtual Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Virtual Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Virtual Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Virtual Clinical Trials, market overview.
Chapter 2: Global Virtual Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of Virtual Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Virtual Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
